FDA issues warning letter for not including the most serious risks in advertisement for medication-assisted treatment drug - FDA Press Releases

FDA issues warning letter to Alkermes, Inc., for misbranding the drug Vivitrol (an extended-release injection formulation of naltrexone) by omitting warnings about the most serious risks associated with the drug from promotional materials

from FDA Press Releases RSS Feed https://ift.tt/2PcE2uE
via IFTTT